NSEShareholders meeting26 Jun 2026 · 26 Jun 2026, 07:20 pm
Shareholders meeting
Sanofi Consumer Healthcare India Limited · SANOFICONR
✦ AI SummaryResults
Sanofi Consumer Healthcare India Limited has held its 3rd Annual General Meeting (AGM) on June 26, 2026, through video conferencing. The meeting was attended by members, directors, auditors, and other participants. The AGM transacted several items of business, including the adoption of annual audited financial statements, declaration of a final dividend, re-appointment of a director, and appointment of statutory auditors.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 26, 2026
Attachments (1)
📄pdf
Download →
SANOFICONSUMER_26062026191934_AGM_Proceedings_s.pdf
View document text
26th June 2026
The Secretary The Secretary
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, C-1, Block G, Exchange Plaza,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400 001 Bandra East, Mumbai - 400 051
Scrip Code: 544250 Symbol: SANOFICONR
Sub.: Summary of Proceedings of the 3rd Annual General Meeting
Dear Sir/Madam,
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings
of the 3rd Annual General Meeting of the Company held today i.e., Friday, 26th June 2026
from 3:00 P.M. (IST) onwards, through Video Conferencing / Other Audio Visual Means facility.
Kindly take the same on records.
Thanking You.
Yours faithfully
For Sanofi Consumer Healthcare India Limited
Nikunjkumar Savaliya
Company Secretary and Compliance Officer
Membership No.: F7048
Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079
Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com
Summary of Proceedings of the 3rd Annual General Meeting
The Company Secretary welcomed the Members to the 3rd Annual General Meeting ("AGM")
of the Company, held on Friday, 26th June 2026, through Video Conferencing ("VC") / Other
Audio-Visual Means ("OAVM"), in compliance with the applicable provisions of the Companies
Act, 2013, the rules made thereunder, the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and the circulars issued
by the Ministry of Corporate Affairs and SEBI from time to time. The Meeting commenced at
3:00 p.m. (IST).
The Company Secretary informed the Members that the Company had provided the facility of
remote e-voting to all Members holding shares as on the cut-off date, i.e., 19th June 2026, in
respect of the businesses set out in the Notice convening the AGM. The remote e-voting facility
remained open from 9:00 a.m. (IST) on Tuesday, 23rd June 2026 until 5:00 p.m. (IST) on Thursday,
25th June 2026. Members who had not cast their votes through remote e-voting were provided
the facility to vote electronically during the AGM.
He further informed the Members that Mr. Omkar Dindorkar (ACS 43029), Partner, or failing him,
Ms. Deepti Kulkarni (ACS 34722), Partner, M/s. MMJB & Associates LLP, Practising Company
Secretaries, had been appointed as the Scrutinizer to scrutinize the remote e-voting process and
e-voting during the AGM in a fair and transparent manner.
He further informed the Members that the combined voting results of the remote e-voting and
e-voting conducted during the AGM, together with the Scrutinizer's Report, would be submitted
to the Stock Exchanges and uploaded on the website of the Company within the prescribed
timelines.
Mr. Amit Jain, Chairman of the Company, chaired the proceedings of the Meeting. After
ascertaining that the requisite quorum was present, he called the Meeting to order and
welcomed the Members, Directors, Auditors and other participants attending the AGM. The
Chairman informed the Members that Ms. Carol-Ann Stewart, Non-Executive Director, was
unable to attend the Meeting due to unavoidable travel commitments.
The Members were informed that the statutory registers and other documents referred to in the
Notice convening the AGM were available for inspection upon request.
The Notice convening the AGM was taken as read. The Chairman further informed the Members
that the Reports of the Statutory Auditors and the Secretarial Auditors did not contain any
qualifications, reservations, adverse remarks and accordingly, the same were also taken as read.
The Chairman then addressed the Members and highlighted the Company's performance and
developments during the financial year 2025.
Thereafter, at the request of the Chairman, Mr. Himanshu Bakshi, Managing Director, addressed
the Members and shared an overview of the Company's business performance, strategic
initiatives and key developments.
Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079
Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com
The Chairman then proceeded with the business of the Meeting and informed the Members that
the resolutions set out in the Notice dated 25th May 2026 convening the AGM had been put to
vote through remote e-voting and e-voting during the AGM.
The following items of business, as set out in the Notice convening the AGM, were transacted:
Item No. Details of the Agenda items Resolution Type
Ordinary Business
1. To receive, consider and adopt the Annual Audited Ordinary
Standalone Financial Statements of the Company for the
year ended 31st December 2025, including the Balance
Sheet as on 31st December 2025, the Statement of Profit
and Loss and the Cash Flow Statement for the Financial Year
ended on that date and Reports of Board of Directors and
Auditors thereon.
2. To declare a final dividend of Rs. 75 per equity share of O rdinary
Rs. 10 each for the Financial Year ended 31st December
2025.
3. To re-appoint Mr. Stanislas Camart, (DIN: 10686945) as Ordinary
Director, who retires by rotation and being eligible, offers
himself for re-appointment.
4. Appointment of M/s. Price Waterhouse & Co Chartered Ordinary
Accountants LLP (Firm Registration No.: 304026E/
E300009) as the Statutory Auditors of the Company
Special Business
5. Appointment of M/s. Price Waterhouse & Co Chartered Ordinary
Accountants LLP (Firm Registration No.: 304026E/E300009)
as the Statutory Auditors of the Company to fill the casual
vacancy
6. Ratification of remuneration to Cost Auditors Ordinary
Thereafter, the Chairman opened the Question & Answer session for the registered speaker
shareholders. 12 speaker shareholders participated in the discussion and sought clarifications on
the financial performance, operations and other matters relating to the Company. The Chairman
and the Management duly addressed the queries raised and suggestions made by the
shareholders during the AGM.
The Chairman informed the Members that the e-voting facility would remain available for 30
minutes after the conclusion of the AGM to enable those Members who had not exercised their
voting rights through remote e-voting to cast their votes electronically.
Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079
Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com
Thereafter, the Chairman formally concluded the proceedings of the AGM by expressing his
sincere appreciation to the Members for their continued trust, support and active participation.
He also acknowledged the valuable contributions of the Board of Directors, employees and other
stakeholders towards the Company's growth and success. The Chairman extended his best wishes
to all present and thanked them for attending the Meeting.
The Annual General Meeting concluded at 5:10 p.m. (IST)
Kindly take the above information on record.
Thanking You.
Yours faithfully
For Sanofi Consumer Healthcare India Limited
Nikunjkumar Savaliya
Company Secretary and Compliance Officer
Membership No.: F7048
Sanofi Consumer Healthcare India Limited, Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai, Maharashtra, 400079
Tel.: +91(22) 4528 8555 Corporate Identity Number: L21002MH2023PLC402652 website: www.sanofi.in Email: igrc.schil@sanofi.com